Hyperglycemia  >>  Symlin (pramlintide)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symlin (pramlintide) / AstraZeneca
NCT00291772: Continuous Subcutaneous Infusion of Pramlintide and Insulin

Completed
4
13
US
Pramlintide, Symlin
Baylor College of Medicine
Type 1 Diabetes
11/07
11/07
NCT00442767: Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus

Completed
4
8
US
Insulin, aspart or lispro, Pramlintide + Insulin, Pramlintide Acetate
Montefiore Medical Center, Amylin Pharmaceuticals, LLC.
Type 1 Diabetes Mellitus
02/09
02/09
NCT01269047: Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia

Completed
4
37
US
Pramlintide, Symlin, Exenatide, Byetta, Type 1 diabetes, Insulin, Novolog, Humalog, Levemir, Lantus
Albert Einstein College of Medicine, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes
08/16
12/16

Download Options